Impact of lung cancer screening on stage migration and mortality among the national Veterans Health Administration population with lung cancer

Despite randomized trials demonstrating a mortality benefit to low-dose computed tomography screening to detect lung cancer, uptake of lung cancer screening (LCS) has been slow, and the benefits of screening remain unclear in clinical practice.